1157. Immune Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) 5 Years After Primary Vaccination of Adults ≥59 Years of Age

por Robertson, Corwin A, Galarza, Katherine, Jacqmein, Jeffry, Selmani, Alexandre, Oster, Philipp
Publicado 2023

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study

por Robertson, Corwin A., Jacqmein, Jeffry, Selmani, Alexandre, Galarza, Katherine, Oster, Philipp
Publicado 2023

Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial

por Robertson, Corwin A., Mercer, Monica, Selmani, Alexandre, Klein, Nicola P., Jeanfreau, Robert, Greenberg, David P.
Publicado 2019